Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FENDER: FMT vs Vancomycin or Fidaxomicin in CDI First Episode or First Recurrence
NCT05266807Phase 3Recruiting
- Start
- Mar 2023
- Primary completion
- Apr 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of Fecal Microbiota Transplantation Capsule in Clostridioides difficile infection (CDI). Started Mar 2023; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT05266807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266807.